Shanghai Pharmaceuticals Holding Co Ltd 2018 SR
The report highlights Shanghai Pharma's 2018 sustainability performance, focusing on R&D innovation, drug quality, and social responsibility. Key achievements include ranking 5th in China for drug R&D product lines and completing consistency evaluations for 27 varieties. The company expanded its distribution network to 24 provinces and launched innovative 'Internet + Medical Health' systems like 'Yiyao Cloud Hospital.' Environmental efforts led to an 11.82% decrease in energy consumption per unit of industrial production. Socially, the 'Shanghai Medical Care Guardian Plan' built 19 hope clinics and trained 197 rural doctors.
Company: Shanghai Pharmaceuticals Holding Co Ltd
Sector: Manufacturing
Country: China
Year: 2018
Type: SR
Pages: 125
Back to company
Shanghai Pharmaceuticals Holding Co Ltd
Corporate Social Responsibility Report
The report highlights Shanghai Pharma's 2018 sustainability performance, focusing on R&D innovation, drug quality, and social responsibility. Key achievements include ranking 5th in China for drug R&D product lines and completing consistency evaluations for 27 varieties. The company expanded its distribution network to 24 provinces and launched innovative 'Internet + Medical Health' systems like 'Yiyao Cloud Hospital.' Environmental efforts led to an 11.82% decrease in energy consumption per unit of industrial production. Socially, the 'Shanghai Medical Care Guardian Plan' built 19 hope clinics and trained 197 rural doctors.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Employees